Skip to main content

Assessment of the US Food and Drug Administration’s Sentinel Analysis Tools: Angiotensin-Converting Enzyme Inhibitors and Angioedema

    Basic Details
    Date
    Type
    Presentation
    Medical Product
    angiotensin-converting enzyme (ACE) inhibitor
    Health Outcome(s)
    angioedema
    Presenter(s)

    Joshua Gagne